|
Dr. Shapiro is a Senior Partner and Chairman of the Board of PureTech Ventures. Formerly he was Executive Vice President in charge of Worldwide Basic, Preclinical, Licensing and External Research for Merck, where he was responsible for programs that resulted in FDA registration of approximately 25 drugs and vaccines. He has been a Board member of a number of life science companies, including VBL, Celera, Momenta, Elixir, Satori, and Ikaria, as well as serving on the Board of Drugs for Neglected Disease Initiative.
|
